Lisinopril liver damage
Pro Research Analysisby 
Searched over 200M research papers
Lisinopril and Liver Damage: A Comprehensive Review
Introduction to Lisinopril and Hepatotoxicity
Lisinopril, an angiotensin-converting enzyme inhibitor (ACE-I), is widely used to manage hypertension and other cardiovascular conditions. While generally well-tolerated, there have been rare but significant reports of lisinopril-induced liver damage, ranging from mild hepatocellular injury to severe, life-threatening conditions.
Case Reports of Lisinopril-Induced Hepatotoxicity
Hepatocellular Damage
Several case reports have documented instances of hepatocellular damage associated with lisinopril. One notable case involved a 30-year-old woman who developed hepatocellular disease eight months after starting lisinopril. Her symptoms included fatigue and jaundice, and laboratory tests revealed elevated liver enzymes. Discontinuation of lisinopril led to a rapid improvement in her condition, with liver enzyme levels normalizing within two months .
Cholestatic Injury
Another case described a 59-year-old woman who developed fulminant hepatic cholestasis after eight weeks of lisinopril therapy. Despite discontinuing the drug, her condition did not fully resolve, and she succumbed to the illness four months later. This case highlights the potential severity of lisinopril-induced liver injury and the possibility of fatal outcomes .
Fulminant Hepatitis
A severe case of fulminant hepatitis was reported in a patient who developed jaundice, fever, and myalgia two weeks after starting lisinopril. Continued use of the drug led to grade III encephalopathy and significant liver function deterioration, underscoring the critical need to discontinue lisinopril at the first sign of liver dysfunction .
Experimental Studies on Lisinopril and Liver Damage
Animal Models
Experimental studies on rats have provided further insights into the hepatotoxic effects of lisinopril. In one study, rats treated with lisinopril showed significant hepatocyte degeneration and elevated serum enzyme levels, indicating liver damage. The study also noted mononuclear cell infiltration, suggesting an inflammatory response .
Protective Effects Against Hepatotoxicity
Interestingly, some studies have explored the protective effects of lisinopril against other forms of liver injury. For instance, lisinopril demonstrated protective effects against acetaminophen-induced hepatotoxicity in rats, reducing oxidative stress markers and normalizing liver enzyme levels . Additionally, lisinopril preconditioning was found to alleviate ischemia-reperfusion injury in rat liver models, reducing oxidative stress and improving liver function 910.
Mechanisms of Lisinopril-Induced Liver Injury
The exact mechanisms underlying lisinopril-induced liver injury are not fully understood. However, several hypotheses have been proposed:
- Oxidative Stress: Lisinopril may induce oxidative stress, leading to hepatocyte damage and inflammation .
- Immune-Mediated Response: The presence of inflammatory cell infiltrates in liver biopsies suggests an immune-mediated mechanism .
- Cholestasis: In some cases, lisinopril may cause cholestasis, leading to bile accumulation and liver damage .
Conclusion
While lisinopril is generally safe and effective for most patients, healthcare providers should be aware of its potential to cause severe liver damage in rare cases. Prompt recognition of symptoms and discontinuation of the drug are crucial to prevent serious outcomes. Further research is needed to elucidate the mechanisms of lisinopril-induced hepatotoxicity and to identify patients at risk.
Sources and full results
Most relevant research papers on this topic
Unique case of presumed lisinopril-induced hepatotoxicity.
Lisinopril-induced hepatotoxicity resolved after discontinuing the drug in a 30-year-old woman with no history of liver-related issues.
DOI